Clinical Inertia and Uncertainty in Medicine

Barriers associated with poor control in Spanish diabetic patients. A consensus study

“…More and more voices justify a quantitative–qualitative research (triangulation of both methodologies). Its objectives are to assess and know the healthcare professional opinions about their experiences and perceptions, and to decrease the inertia and therapeutic incompliance resulting in a wide knowledge of the barriers with influence on inertia and incompliance . Recent publications on this matter, using qualitative techniques, concluded that there were several reasons given by the physicians to not intensify the pharmacologic therapy.…”

“…The data shows that other factors are more common. The lack of familiarity with guidelines, lack of confidence in the ability or preparation and external barriers such as limited time can explain better why physicians do not follow practice guidelines (16)(17)(18)(19)(20)(21).…”

“…) and 16 in nursing ( ıtems2,5,6,9,10,13,14,15,16,17,20,21,27,30, 34 and 35) (Figure S1).The results of the second round are shown in Figures S1 and S2. There were 18 consensus statements in medicine (items1,4,5,12,18,21,25,27,28,29,30,32, 34, 35, 36, 38, 39 and 41) (Figure S2) and 16 in nursing (items7,8,11,12,18,24,25,28,29,31,32, 36, 37, 38, 39, and 41) (…”

The Effectiveness of a Computer Reminder System for Laboratory Monitoring of Metabolic Syndrome in Schizophrenic Outpatients Using Second-generation Antipsychotics

“…This clinical phenomenon also occurs in patients with hypertension, dyslipidemia, or diabetes [12]. Many experts have noticed this problem [13,14] and Philips et al defined the term as clinical inertia meaning "the failure of health care providers to initiate or intensify therapy when indicated" [15]. They also advise that a reminder system and performance feedback mechanism can improve the quality of providing necessary care.…”

Managing gout needs more than drugs: ‘Il faut le savoir-faire, l'Art et la manière’

“…Although not widely considered in the gout literature, this phenomenon of therapeutic inertia 20 has been well known in the management of diabetes for decades, with at least 108 PubMed references relating to its occurrence. In this field, it has been well established that despite the observation of insufficient glycaemic control, physicians do not systematically increase drug treatments,21 and this has been attributed to ‘clinical inertia’ 22…”